A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report.
Falcão F, Viegas E, Carmo I, Soares J, Falcao M, Solano M, Cavaco P, Mendes D, Rijo J, Povoa P, Pais Martins A, Carmo E, Mansinho K, Fonseca C, Campos L, Carvalho A, Mirco A, Farinha H, Aldir I, Correia J.
Falcão F, et al. Among authors: mansinho k.
Eur J Hosp Pharm. 2021 Sep;28(5):248-253. doi: 10.1136/ejhpharm-2020-002613. Epub 2021 Jan 15.
Eur J Hosp Pharm. 2021.
PMID: 33452110
Free PMC article.